000 | a | ||
---|---|---|---|
999 |
_c7837 _d7837 |
||
003 | OSt | ||
005 | 20181208100212.0 | ||
008 | 181208b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_96893 _aArchana |
||
245 | _aSynthesis and biological evaluation of some novel benzodiazepine containing benzothiazepine/benzoxazepine derivatives as potent anticonvulsant agents | ||
250 | _aVol. 55 (06) June | ||
260 |
_aMumbai _bIndian Drug Manufacture's Association - IDMA _c2018 |
||
300 | _a7-13 | ||
520 | _aA new series of 4-benzodiazepinyl-2-( substituted phenyl)-1,5-benzothiazepines (3a-3f) and 4-benzodiazepinyl-2-(substituted phenyl)-1,5-benzoxazepines (4a-4f) were synthesised and evaluated for their anticonvulsant activity. All these compounds were screened in vivo, for their anticonvulsant activity and acute toxicity. Compound 4-benzodiazepinyl-2-(p-methoxy phenyl)-1,5-benzothiazepine 4b, was found to be most potent compoundof this series, more potent than standard drug phenytoin sodium. The homogeneity of all the compounds was checked by TLC. The structures of these compounds have been established by elemental analysis, IR and 1H NMR spectroscopy. | ||
650 | 0 |
_94639 _aPHARMACEUTICS |
|
773 | 0 |
_dMumbai Indian Drug Manufactures Association _tIndian drugs |
|
942 |
_2ddc _cAR |